biomodal

biomodal (formerly known as Cambridge Epigenetix) is a UK-based developer of early cancer detection technologies, providing users with diagnostic screening and testing services for colorectal cancer and other common tumors. Our product platform, SingleShot®, can simultaneously generate genetic and epigenetic information while offering significant cost advantages for DNA analysis. Our product portfolio includes tailored applications for rare variant detection, whole-genome sequencing, and epigenetic analysis. These products will be compatible with various formats while delivering disruptive improvements in detection sensitivity and cost.